These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8947426)

  • 1. Blood doping and erythropoietin. The effects of variation in hemoglobin concentration and other related factors on physical performance.
    Ekblom B
    Am J Sports Med; 1996; 24(6 Suppl):S40-2. PubMed ID: 8947426
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of exercise on the secondary blood markers commonly used to suspect erythropoietin doping.
    Robinson N; Saugy M; Mangin P
    Clin Lab; 2003; 49(1-2):57-62. PubMed ID: 12593476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American College of Sports Medicine position stand. The use of blood doping as an ergogenic aid.
    Sawka MN; Joyner MJ; Miles DS; Robertson RJ; Spriet LL; Young AJ
    Med Sci Sports Exerc; 1996 Jun; 28(6):i-viii. PubMed ID: 8926864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin in exercise adaptation.
    Burge CM
    Exerc Sport Sci Rev; 2010 Apr; 38(2):41. PubMed ID: 20335734
    [No Abstract]   [Full Text] [Related]  

  • 5. Procedures for monitoring recombinant erythropoietin and analogs in doping.
    Lamon S; Robinson N; Saugy M
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):141-54, x. PubMed ID: 20122455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hematocrit paradox--how does blood doping really work?
    Böning D; Maassen N; Pries A
    Int J Sports Med; 2011 Apr; 32(4):242-6. PubMed ID: 20617487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No proof for augmented arterial oxygen content as only factor influencing exercise capacity after Epo doping.
    Böning D; Maassen N; Pries A
    J Appl Physiol (1985); 2008 Dec; 105(6):1988; author reply 1989. PubMed ID: 19050342
    [No Abstract]   [Full Text] [Related]  

  • 8. Total hemoglobin mass--a new parameter to detect blood doping?
    Prommer N; Sottas PE; Schoch C; Schumacher YO; Schmidt W
    Med Sci Sports Exerc; 2008 Dec; 40(12):2112-8. PubMed ID: 18981937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
    Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
    Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal variation of hemoglobin and reticulocytes in elite rowers.
    Ashenden MJ; Lacoste A; Orhant E; Audran M; Sharpe K
    Haematologica; 2004 Nov; 89(11):1403-4. PubMed ID: 15531469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Doping in endurance sports. Survey of individual [Hb] levels can expose doping].
    Ekblom B; Holmberg HC; Eriksson K
    Lakartidningen; 2001 Nov; 98(48):5490-2, 5495-6. PubMed ID: 11769364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematologic passport for athletes competing in endurance sports: a feasibility study.
    Malcovati L; Pascutto C; Cazzola M
    Haematologica; 2003 May; 88(5):570-81. PubMed ID: 12745277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment on ‘"The hybrid algorithm (Hbmr) to fight against blood doping in sports"’ by F. Sanchis-Gomar et al.
    Schumacher YO; Pottgiesser T
    Scand J Med Sci Sports; 2010 Dec; 20(6):791. PubMed ID: 21182671
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood boosting today].
    Audran M; Varlet-Marie E
    Bull Acad Natl Med; 2004; 188(6):945-53. PubMed ID: 15651424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin and other blood-boosting methods.
    Pommering TL
    Pediatr Clin North Am; 2007 Aug; 54(4):691-9, x. PubMed ID: 17723871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced erythrocythemia and athletic performance.
    Simon TL
    Semin Hematol; 1994 Apr; 31(2):128-33. PubMed ID: 8066469
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oxygen blood transport and doping].
    Audran M; Connes P; Varlet-Marie E
    Bull Acad Natl Med; 2003; 187(9):1669-79; discussion 1680-3. PubMed ID: 15369237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comments on Delanghe and Joyner's editorial "testing for recombinant human erythropoietin". Preanalytical and analytical issues in indirect hematological testing.
    Lippi G; Banfi G
    J Appl Physiol (1985); 2008 Dec; 105(6):1990-1. PubMed ID: 19050344
    [No Abstract]   [Full Text] [Related]  

  • 19. Doping in sport--exercise scientists have to take responsibility.
    Kuipers H
    Int J Sports Med; 2001 Nov; 22(8):545. PubMed ID: 11719887
    [No Abstract]   [Full Text] [Related]  

  • 20. [Point of view on doping].
    Naeije R; Pagnamenta A
    Rev Med Brux; 1999 Jun; 20(3):153-8. PubMed ID: 10429539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.